Exane BNP Paribas Begins Coverage of Synopsys with Underperform Rating and Sets Price Target at $425
Written by Emily J. Thompson, Senior Investment Analyst
Source: Benzinga
Updated: Oct 02 2025
0mins
Source: Benzinga
Real-time Intelligence: Benzinga Pro offers the fastest news alerts to help traders stay informed and make winning trades in the stock market.
Exclusive Community: Joining Benzinga Pro connects users with over 10,000 serious traders and provides access to exclusive stories and insights from Benzinga reporters.
SNPS.O$0.0000%Past 6 months

No Data
Analyst Views on SNPS
Wall Street analysts forecast SNPS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNPS is 559.38 USD with a low forecast of 425.00 USD and a high forecast of 630.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Wall Street analysts forecast SNPS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SNPS is 559.38 USD with a low forecast of 425.00 USD and a high forecast of 630.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
Current: 477.260

Current: 477.260

maintain
$550 -> $580
Reason
Needham raised the firm's price target on Synopsys to $580 from $550 and keeps a Buy rating on the shares. The company issued the first FY26 outlook that is slightly below the Street in revenue but decently above consensus in earnings, the analyst tells investors in a research note. Investors had been expecting a rocky FY26 guide given the typical post-M&A integration risks, but that Synopsys is guiding largely in-line and slightly better than the Street is certainly a pleasant surprise, the firm added.
Overweight
maintain
$575 -> $600
Reason
KeyBanc analyst Jason Celino raised the firm's price target on Synopsys to $600 from $575 and keeps an Overweight rating on the shares. The firm notes Synopsys posted modestly better Q4 revenue and EPS, and solid backlog of $11.4B. More importantly, the initial FY26 EPS outlook is meaningfully better than expected, driven by accelerated debt pay-down and cost synergies. KeyBanc is encouraged by the better bottom-line outlook.
downgrade
$630 -> $602
Reason
Piper Sandler lowered the firm's price target on Synopsys to $602 from $630 and keeps an Overweight rating on the shares. The firm would argue that Synopsys largely achieved what was needed. That said, organic EDA growth and free cash flow margins are likely to be the main nagging items coming out of the quarter. The company was not precise in its EDA vs. IP growth assumptions, but Piper believes FY26 guidance points to high single digit overall organic growth and low-double digits organic EDA growth.
Neutral -> Buy
upgrade
$500 -> $560
Reason
BofA upgraded Synopsys to Buy from Neutral with a price target of $560, up from $500.
About SNPS
Synopsys, Inc. is engaged in providing engineering solutions from silicon to systems, enabling customers to innovate artificial intelligence (AI)-powered products. It delivers silicon design, intellectual property (IP), simulation and analysis solutions, and design services. It supplies mission-critical electronic design automation (EDA) software that engineers use to design and test integrated circuits (ICs). Its Design Automation segment includes its advanced silicon design, verification products and services and system integration products. This segment also includes digital, custom and field programmable gate arrays, integrated circuit design software, verification software and hardware products, system integration products and services, and manufacturing software products. Its Design IP segment includes its interface, foundation, security, and embedded processor IP, IP subsystems, and IP implementation services that serve companies in the semiconductor and electronics industries.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.